Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 07, 2021

SELL
$102.3 - $112.62 $13,299 - $14,640
-130 Closed
0 $0
Q4 2019

Mar 19, 2020

BUY
$72.13 - $90.25 $9,376 - $11,732
130 New
130 $11,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sowa Financial Group, Inc. Portfolio

Follow Sowa Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowa Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sowa Financial Group, Inc. with notifications on news.